EW
CTSH icon

Evoke Wealth’s Cognizant CTSH Stock Holding History

Evoke Wealth’s Portfolio CTSH Stock Details CTSH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-761
Closed -$44K – 540
2022
Q3 		$44K Sell
761
-191
-20% -$12.5K ﹤0.01% 532
2022
Q2 		$64K Sell
952
-88
-8% -$6.74K ﹤0.01% 472
2022
Q1 		$93K Buy
1,040
+96
+10% +$8.44K ﹤0.01% 443
2021
Q4 		$84K Buy
944
+413
+78% +$33.2K ﹤0.01% 471
2021
Q3 		$39K Hold
531
– – ﹤0.01% 541
2021
Q2 		$37K Sell
531
-23
-4% -$1.71K ﹤0.01% 559
2021
Q1 		$43K Buy
554
+275
+99% +$21.2K ﹤0.01% 471
2020
Q4 		$23K Sell
279
-5
-2% -$381 ﹤0.01% 475
2020
Q3 		$20K Hold
284
– – ﹤0.01% 475
2020
Q2 		$16K Sell
284
-15
-5% -$806 ﹤0.01% 499
2020
Q1 		$13.9K Sell
299
-362
-55% -$21.6K ﹤0.01% 480
2019
Q4 		$41K Sell
661
-3,750
-85% -$232K 0.01% 455
2019
Q3 		$266K Buy
+4,411
New +$279K 0.03% 221

Other funds holding CTSH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Evoke Wealth's CTSH Position: Q4 2022 in Review

Evoke Wealth sold out of Cognizant (CTSH) in Q4 2022, closing a stake of 761 shares — an estimated $44K sold.

Evoke Wealth first reported a position in CTSH in Q3 2019 and held it in 13 quarters. The position peaked at $266K in Q3 2019. 865 funds tracked by Wall St. Rank hold CTSH as of Q4 2022.

  • Evoke Wealth reported no remaining Cognizant position as of Q4 2022 after selling out during the quarter.
  • Evoke Wealth sold 761 Cognizant shares in Q4 2022, an estimated $44K.
  • Evoke Wealth first reported a position in Cognizant in Q3 2019 and held it in 13 quarters.
  • Evoke Wealth's Cognizant position peaked at $266K in Q3 2019.
  • 865 funds tracked by Wall St. Rank held Cognizant as of Q4 2022.

Based on Evoke Wealth's 13F filing for Q4 2022, filed 10 Feb 2023.